Online Inquiry
Cat.#: ACPP-1206
| Despition | ELOVL4 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1082 | Human CACYBP Protein (AC1082) | 5 µg | inquiry |
| ACPP-1218 | Dopamine D2 Receptor Blocking Peptide (AC1218) | 250 µg | inquiry |
| ACPP-1118 | Human Insulin (Active) (AC1118) | 25 mg | inquiry |
| ACPP-1383 | Human KLF7 Protein (AC1383) | 5 µg | inquiry |
| ACPP-1356 | GIRK2 Blocking Peptide (AC1356) | 250 µg | inquiry |
| ACPP-1257 | MC4 Receptor Blocking Peptide (AC1257) | 250 µg | inquiry |
| ACPP-1720 | Human PNPO Protein (AC1720) | 5 µg | inquiry |
| ACPP-1271 | Alpha Synuclein Blocking Peptide (AC1271) | 250 µg | inquiry |
| ACPP-1247 | GSK3 beta Blocking Peptide (AC1247) | 250 µg | inquiry |
| ACPP-1235 | C1orf187 Blocking Peptide (AC1235) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.